1
|
Bae D, Lee KH, Kim MJ. Growth methodologies of boron nitride nanotubes and their neutron shielding applications: a review. NANOSCALE 2024; 16:3817-3837. [PMID: 38327235 DOI: 10.1039/d3nr06070e] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 02/09/2024]
Abstract
This review provides a comprehensive overview of the growth methodologies and neutron shielding applications of Boron Nitride Nanotubes (BNNTs). BNNTs have garnered significant attention because of their unique combination of high thermal stability, mechanical strength, and exceptional neutron absorption properties. Synthesis methods for BNNTs, including laser ablation, thermal plasma treatment, chemical vapour deposition (CVD), and ball milling have been thoroughly examined, highlighting their mechanisms, advantages, and challenges. Each method contributes uniquely to the quality and applicability of BNNTs in terms of scalability and production efficiency. This study focused on the applications of BNNTs in neutron absorption, particularly in aerospace engineering. BNNTs have shown promising potential in enhancing the safety and longevity of space missions by providing effective radiation protection. Furthermore, their potential in medical applications, particularly in Boron Neutron Capture Therapy (BNCT) for cancer treatment, has been explored. BNCT offers a targeted approach to cancer therapy by utilizing the high boron-10 content of BNNTs for precise and localized treatment. This review also provides an outlook on the future of BNNT research, emphasizing the need for more efficient growth methods to facilitate wider adoption and commercialization. The versatility of BNNTs across various fields, from space exploration to medical science, underscores their potential as materials of significant scientific and technological importance. As research progresses, BNNTs are expected to play a pivotal role in advancing materials science and offer innovative solutions to complex challenges.
Collapse
Affiliation(s)
- Dongsu Bae
- Department of Chemical Engineering, Pohang University of Science and Technology, 77 Cheongam-ro, Nam-Gu, Pohang, Gyeongbuk 37673, Republic of Korea
| | - Kun-Hong Lee
- Department of Chemical Engineering, Pohang University of Science and Technology, 77 Cheongam-ro, Nam-Gu, Pohang, Gyeongbuk 37673, Republic of Korea
| | - Myung Jong Kim
- Department of Chemistry, Gachon University, 1342 Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, 13120, Republic of Korea.
| |
Collapse
|
2
|
Ghosh S, Lee SJ, Hsu JC, Chakraborty S, Chakravarty R, Cai W. Cancer Brachytherapy at the Nanoscale: An Emerging Paradigm. CHEMICAL & BIOMEDICAL IMAGING 2024; 2:4-26. [PMID: 38274040 PMCID: PMC10806911 DOI: 10.1021/cbmi.3c00092] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 09/01/2023] [Revised: 10/09/2023] [Accepted: 11/01/2023] [Indexed: 01/27/2024]
Abstract
Brachytherapy is an established treatment modality that has been globally utilized for the therapy of malignant solid tumors. However, classic therapeutic sealed sources used in brachytherapy must be surgically implanted directly into the tumor site and removed after the requisite period of treatment. In order to avoid the trauma involved in the surgical procedures and prevent undesirable radioactive distribution at the cancerous site, well-dispersed radiolabeled nanomaterials are now being explored for brachytherapy applications. This emerging field has been coined "nanoscale brachytherapy". Despite present-day advancements, an ongoing challenge is obtaining an advanced, functional nanomaterial that concurrently incorporates features of high radiolabeling yield, short labeling time, good radiolabeling stability, and long tumor retention time without leakage of radioactivity to the nontargeted organs. Further, attachment of suitable targeting ligands to the nanoplatforms would widen the nanoscale brachytherapy approach to tumors expressing various phenotypes. Molecular imaging using radiolabeled nanoplatforms enables noninvasive visualization of cellular functions and biological processes in vivo. In vivo imaging also aids in visualizing the localization and retention of the radiolabeled nanoplatforms at the tumor site for the requisite time period to render safe and effective therapy. Herein, we review the advancements over the last several years in the synthesis and use of functionalized radiolabeled nanoplatforms as a noninvasive substitute to standard brachytherapy sources. The limitations of present-day brachytherapy sealed sources are analyzed, while highlighting the advantages of using radiolabeled nanoparticles (NPs) for this purpose. The recent progress in the development of different radiolabeling methods, delivery techniques and nanoparticle internalization mechanisms are discussed. The preclinical studies performed to date are summarized with an emphasis on the current challenges toward the future translation of nanoscale brachytherapy in routine clinical practices.
Collapse
Affiliation(s)
- Sanchita Ghosh
- Radiopharmaceuticals
Division, Bhabha Atomic Research Centre, Trombay, Mumbai 400085, India
- Homi
Bhabha National Institute, Anushaktinagar, Mumbai 400094, India
| | - Sophia J. Lee
- Departments
of Radiology and Medical Physics, University
of Wisconsin-Madison, Madison, Wisconsin 53705, United States
| | - Jessica C. Hsu
- Departments
of Radiology and Medical Physics, University
of Wisconsin-Madison, Madison, Wisconsin 53705, United States
| | - Sudipta Chakraborty
- Radiopharmaceuticals
Division, Bhabha Atomic Research Centre, Trombay, Mumbai 400085, India
- Homi
Bhabha National Institute, Anushaktinagar, Mumbai 400094, India
| | - Rubel Chakravarty
- Radiopharmaceuticals
Division, Bhabha Atomic Research Centre, Trombay, Mumbai 400085, India
- Homi
Bhabha National Institute, Anushaktinagar, Mumbai 400094, India
| | - Weibo Cai
- Departments
of Radiology and Medical Physics, University
of Wisconsin-Madison, Madison, Wisconsin 53705, United States
| |
Collapse
|
3
|
Mohsin MH, Khashan KS, Sulaiman GM, Mohammed HA, Qureshi KA, Aspatwar A. A novel facile synthesis of metal nitride@metal oxide (BN/Gd 2O 3) nanocomposite and their antibacterial and anticancer activities. Sci Rep 2023; 13:22749. [PMID: 38123673 PMCID: PMC10733422 DOI: 10.1038/s41598-023-49895-4] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/20/2023] [Accepted: 12/13/2023] [Indexed: 12/23/2023] Open
Abstract
In this study, a novel core/shell nanocomposite structure (h-BN@Gd2O3 NCs) was created for the first time by combining hexagonal boron nitride (h-BN) with doped gadolinium oxide (Gd2O3) using different laser pulse numbers, i.e., 150, 338, and 772 pulses. We employed various analytical techniques, including mapping analysis, FE-SEM, EDS, HRTEM, SAED, XRD, zeta potential analysis, DLS, FTIR, Raman spectroscopy, and PL measurements, to characterize the synthesized h-BN, c-Gd2O3, and h-BN@Gd2O3 NCs (338 pulses). XRD results indicated hexagonal and cubic crystal structures for BN and Gd2O3, respectively, while EDS confirmed their chemical composition and elemental mapping. Chemical bonds between B-N-Gd, B-N-O, and Gd-O bands at 412, 455, 474, and 520 cm-1 were identified by FTIR analysis. The antimicrobial and anticancer activities of these NCs using agar well diffusion and MTT assays. They exhibited potent antibacterial properties against both Gram-positive and Gram-negative pathogens. Furthermore, NCs have reduced the proliferation of cancerous cells, i.e., human colon adenocarcinoma cells (HT-29) and human breast cancer cells (MCF-7), while not affecting the proliferation of the normal breast cell line (MCF-10). The anticancer efficacy of NCs was validated by the AO/EtBr assay, which confirmed apoptotic cell death. Blood compatibility on human erythrocytes was also confirmed by hemolytic and in vitro toxicity assessments. The compiled results of the study proposed these nanoparticles could be used as a promising drug delivery system and potentially in healthcare applications.
Collapse
Affiliation(s)
- Mayyadah H Mohsin
- Department of Applied Sciences, University of Technology, Baghdad, Iraq
| | - Khawla S Khashan
- Department of Applied Sciences, University of Technology, Baghdad, Iraq
| | - Ghassan M Sulaiman
- Department of Applied Sciences, University of Technology, Baghdad, Iraq.
| | - Hamdoon A Mohammed
- Department of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, Qassim University, 51452, Qassim, Saudi Arabia
- Department of Pharmacognosy and Medicinal Plants, Faculty of Pharmacy, Al-Azhar University, Cairo, 11884, Egypt
| | - Kamal A Qureshi
- Faculty of Medicine and Health Technology, Tampere University, 33520, Tampere, Finland
| | - Ashok Aspatwar
- Faculty of Medicine and Health Technology, Tampere University, 33520, Tampere, Finland.
| |
Collapse
|
4
|
Goel M, Mackeyev Y, Krishnan S. Radiolabeled nanomaterial for cancer diagnostics and therapeutics: principles and concepts. Cancer Nanotechnol 2023; 14:15. [PMID: 36865684 PMCID: PMC9968708 DOI: 10.1186/s12645-023-00165-y] [Citation(s) in RCA: 12] [Impact Index Per Article: 12.0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/04/2023] [Accepted: 02/13/2023] [Indexed: 03/01/2023] Open
Abstract
In the last three decades, radiopharmaceuticals have proven their effectiveness for cancer diagnosis and therapy. In parallel, the advances in nanotechnology have fueled a plethora of applications in biology and medicine. A convergence of these disciplines has emerged more recently with the advent of nanotechnology-aided radiopharmaceuticals. Capitalizing on the unique physical and functional properties of nanoparticles, radiolabeled nanomaterials or nano-radiopharmaceuticals have the potential to enhance imaging and therapy of human diseases. This article provides an overview of various radionuclides used in diagnostic, therapeutic, and theranostic applications, radionuclide production through different techniques, conventional radionuclide delivery systems, and advancements in the delivery systems for nanomaterials. The review also provides insights into fundamental concepts necessary to improve currently available radionuclide agents and formulate new nano-radiopharmaceuticals.
Collapse
Affiliation(s)
- Muskan Goel
- Amity School of Applied Sciences, Amity University, Gurugram, Haryana 122413 India
| | - Yuri Mackeyev
- Vivian L. Smith Department of Neurosurgery, University of Texas Health Science Center, Houston, TX 77030 USA
| | - Sunil Krishnan
- Vivian L. Smith Department of Neurosurgery, University of Texas Health Science Center, Houston, TX 77030 USA
| |
Collapse
|
5
|
Ailuno G, Balboni A, Caviglioli G, Lai F, Barbieri F, Dellacasagrande I, Florio T, Baldassari S. Boron Vehiculating Nanosystems for Neutron Capture Therapy in Cancer Treatment. Cells 2022; 11:cells11244029. [PMID: 36552793 PMCID: PMC9776957 DOI: 10.3390/cells11244029] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/02/2022] [Revised: 12/09/2022] [Accepted: 12/11/2022] [Indexed: 12/15/2022] Open
Abstract
Boron neutron capture therapy is a low-invasive cancer therapy based on the neutron fission process that occurs upon thermal neutron irradiation of 10B-containing compounds; this process causes the release of alpha particles that selectively damage cancer cells. Although several clinical studies involving mercaptoundecahydro-closo-dodecaborate and the boronophenylalanine-fructose complex are currently ongoing, the success of this promising anticancer therapy is hampered by the lack of appropriate drug delivery systems to selectively carry therapeutic concentrations of boron atoms to cancer tissues, allowing prolonged boron retention therein and avoiding the damage of healthy tissues. To achieve these goals, numerous research groups have explored the possibility to formulate nanoparticulate systems for boron delivery. In this review. we report the newest developments on boron vehiculating drug delivery systems based on nanoparticles, distinguished on the basis of the type of carrier used, with a specific focus on the formulation aspects.
Collapse
Affiliation(s)
- Giorgia Ailuno
- Department of Pharmacy, University of Genova, 16147 Genova, Italy
- Correspondence: (G.A.); (T.F.)
| | - Alice Balboni
- Department of Pharmacy, University of Genova, 16147 Genova, Italy
| | | | - Francesco Lai
- Department of Life and Environmental Sciences (DiSVA), University of Cagliari, 09124 Cagliari, Italy
| | - Federica Barbieri
- Department of Internal Medicine, University of Genova, 16132 Genova, Italy
| | | | - Tullio Florio
- Department of Internal Medicine, University of Genova, 16132 Genova, Italy
- IRCCS Ospedale Policlinico San Martino, 16132 Genova, Italy
- Correspondence: (G.A.); (T.F.)
| | - Sara Baldassari
- Department of Pharmacy, University of Genova, 16147 Genova, Italy
| |
Collapse
|
6
|
Kakarla AB, Kong I. In Vitro and In Vivo Cytotoxicity of Boron Nitride Nanotubes: A Systematic Review. NANOMATERIALS (BASEL, SWITZERLAND) 2022; 12:2069. [PMID: 35745407 PMCID: PMC9229602 DOI: 10.3390/nano12122069] [Citation(s) in RCA: 12] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 05/10/2022] [Revised: 06/08/2022] [Accepted: 06/09/2022] [Indexed: 12/17/2022]
Abstract
Boron nitride nanotubes (BNNTs) are an exciting class of nanomaterials due to their unique chemical and physical characteristics. In recent decades, BNNTs have gained huge attention in research and development for various applications, including as nano-fillers for composites, semiconductor devices, hydrogen storage, and as an emerging material in biomedical and tissue engineering applications. However, the toxicity of BNNTs is not clear, and the biocompatibility is not proven yet. In this review, the role of BNNTs in biocompatibility studies is assessed in terms of their characteristics: cell viability, proliferation, therapeutic outcomes, and genotoxicity, which are vital elements for their prospective use in biomedical applications. A systematic review was conducted utilising the databases Scopus and Web of Science (WOS) (2008-2022). Additional findings were discovered manually by snowballing the reference lists of appropriate reviews. Only English-language articles were included. Finally, the significant analysis and discussion of the chosen articles are presented.
Collapse
Affiliation(s)
| | - Ing Kong
- School of Computing, Engineering and Mathematical Sciences, La Trobe University, Bendigo, VIC 3552, Australia;
| |
Collapse
|
7
|
Jalilian AR, Shahi A, Swainson IP, Nakamura H, Venkatesh M, Osso JA. Potential Theranostic Boron Neutron Capture Therapy Agents as Multimodal Radiopharmaceuticals. Cancer Biother Radiopharm 2022; 37:342-354. [DOI: 10.1089/cbr.2021.0276] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Affiliation(s)
- Amir R. Jalilian
- Nuclear Sciences and Applications Department, International Atomic Energy Agency, Vienna, Austria
| | - Arman Shahi
- Faculty of Science, McMaster University, Hamilton, Canada
| | - Ian P. Swainson
- Nuclear Sciences and Applications Department, International Atomic Energy Agency, Vienna, Austria
| | - Hiroyuki Nakamura
- Laboratory for Chemistry and Life Science, Institute of Innovative Research, Tokyo Institute of Technology, Midori-ku, Yokohama, Japan
| | - Meera Venkatesh
- Nuclear Sciences and Applications Department, International Atomic Energy Agency, Vienna, Austria
| | - Joao A. Osso
- Nuclear Sciences and Applications Department, International Atomic Energy Agency, Vienna, Austria
| |
Collapse
|
8
|
Turhan EA, Pazarçeviren AE, Evis Z, Tezcaner A. Properties and applications of boron nitride nanotubes. NANOTECHNOLOGY 2022; 33:242001. [PMID: 35203072 DOI: 10.1088/1361-6528/ac5839] [Citation(s) in RCA: 9] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/01/2021] [Accepted: 02/24/2022] [Indexed: 06/14/2023]
Abstract
Nanomaterials have received increasing attention due to their controllable physical and chemical properties and their improved performance over their bulk structures during the last years. Carbon nanostructures are one of the most widely searched materials for use in different applications ranging from electronic to biomedical because of their exceptional physical and chemical properties. However, BN nanostructures surpassed the attention of the carbon-based nanostructure because of their enhanced thermal and chemical stabilities in addition to structural similarity with the carbon nanomaterials. Among these nanostructures, one dimensional-BN nanostructures are on the verge of development as new materials to fulfill some necessities for different application areas based on their excellent and unique properties including their tunable surface and bandgap, electronic, optical, mechanical, thermal, and chemical stability. Synthesis of high-quality boron nitride nanotubes (BNNTs) in large quantities with novel techniques provided greater access, and increased their potential use in nanocomposites, biomedical fields, and nanodevices as well as hydrogen uptake applications. In this review, properties and applications of one-dimensional BN (1D) nanotubes, nanofibers, and nanorods in hydrogen uptake, biomedical field, and nanodevices are discussed in depth. Additionally, research on native and modified forms of BNNTs and also their composites with different materials to further improve electronic, optical, structural, mechanical, chemical, and biological properties are also reviewed. BNNTs find many applications in different areas, however, they still need to be further studied for improving the synthesis methods and finding new possible future applications.
Collapse
Affiliation(s)
- Emine Ayşe Turhan
- Department of Material Science and Engineering, Koç University, İstanbul, Turkey
| | | | - Zafer Evis
- Department of Engineering Sciences, Middle East Technical University, Ankara, Turkey
| | - Ayşen Tezcaner
- Department of Engineering Sciences, Middle East Technical University, Ankara, Turkey
- Center of Excellence in Biomaterials and Tissue Engineering, Ankara, Turkey
| |
Collapse
|
9
|
Silva WM, Ribeiro H, Taha-Tijerina JJ. Potential Production of Theranostic Boron Nitride Nanotubes ( 64Cu-BNNTs) Radiolabeled by Neutron Capture. NANOMATERIALS (BASEL, SWITZERLAND) 2021; 11:2907. [PMID: 34835671 PMCID: PMC8620178 DOI: 10.3390/nano11112907] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 09/01/2021] [Revised: 10/14/2021] [Accepted: 10/17/2021] [Indexed: 11/16/2022]
Abstract
In this work, the radioisotope 64Cu was obtained from copper (II) chloride dihydrate in a nuclear research reactor by neutron capture, (63Cu(n,γ)64Cu), and incorporated into boron nitride nanotubes (BNNTs) using a solvothermal process. The produced 64Cu-BNNTs were analyzed by TEM, MEV, FTIR, XDR, XPS and gamma spectrometry, with which it was possible to observe the formation of64Cu nanoparticles, with sizes of up to 16 nm, distributed through nanotubes. The synthesized of 64Cu nanostructures showed a pure photoemission peak of 511 keV, which is characteristic of gamma radiation. This type of emission is desirable for Photon Emission Tomography (PET scan) image acquisition, as well as its use in several cancer treatments. Thus, 64Cu-BNNTs present an excellent alternative as theranostic nanomaterials that can be used in diagnosis and therapy by different techniques used in nuclear medicine.
Collapse
Affiliation(s)
- Wellington Marcos Silva
- Departamento de Química, Universidade Federal de Minas Gerais, Avenida Presidente Antônio Carlos, 6.627, Belo Horizonte 31270-901, MG, Brazil;
| | - Helio Ribeiro
- Escola de Engenharia, Mackenzie Presbyterian University, Rua da Consolação 896, São Paulo 01302-907, SP, Brazil;
| | - Jose Jaime Taha-Tijerina
- Departamento de Ingeniería, Universidad de Monterrey, Av. Ignacio Morones Prieto 4500 Pte., San Pedro Garza García 66238, NL, Mexico
- Engineering Technology Department, University of Texas Rio Grande Valley, Brownsville, TX 78520, USA
| |
Collapse
|
10
|
Kode VR, Hinkle KR, Ao G. Interaction of DNA-Complexed Boron Nitride Nanotubes and Cosolvents Impacts Dispersion and Length Characteristics. LANGMUIR : THE ACS JOURNAL OF SURFACES AND COLLOIDS 2021; 37:10934-10944. [PMID: 34496213 DOI: 10.1021/acs.langmuir.1c01309] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/13/2023]
Abstract
Processing boron nitride nanotubes (BNNTs) for applications ranging from nanomedicine to electronics generally requires dispersions of nanotubes that are stable in various compounds and solvents. We show that alcohol/water cosolvents, particularly isopropyl alcohol (IPA), are essential for the complexation of BNNTs with DNA under mild bath sonication. The resulting DNA-wrapped BNNT complexes are highly stable during purification and solvent exchange from cosolvents to water, providing potential for the versatile liquid-phase processing of BNNTs. Via molecular dynamics simulations, we demonstrate that IPA assists in the solvation of BNNTs due to its pseudosurfactant nature by verifying that water is replaced in the solvation layer as IPA is added. We quantify the solvation free energy of BNNTs in various IPA/water mixtures and observe a nonmonotonic trend, highlighting the importance of utilizing solvent-nanotube interactions in nanomaterial dispersions. Additionally, we show that nanotube lengths can be characterized by rheology measurements via determining the viscosity of dilute dispersions of DNA-BNNTs. This represents the bulk sample property in the liquid state, as compared to conventional imaging techniques that require surface deposition and drying. Our results also demonstrate that BNNT dispersions exhibit the rheological behavior of dilute Brownian rigid rods, which can be further exploited for the controlled processing and property enhancement of BNNT-enabled assemblies such as films and fibers.
Collapse
Affiliation(s)
- Venkateswara R Kode
- Department of Chemical and Biomedical Engineering, Washkewicz College of Engineering, Cleveland State University, 2121 Euclid Avenue, Cleveland, Ohio 44115, United States
| | - Kevin R Hinkle
- Department of Chemical and Materials Engineering, University of Dayton, 300 College Park, Dayton, Ohio 45469, United States
| | - Geyou Ao
- Department of Chemical and Biomedical Engineering, Washkewicz College of Engineering, Cleveland State University, 2121 Euclid Avenue, Cleveland, Ohio 44115, United States
| |
Collapse
|
11
|
Korolkov IV, Zibert AV, Lissovskaya LI, Ludzik K, Anisovich M, Kozlovskiy AL, Shumskaya AE, Vasilyeva M, Shlimas DI, Jażdżewska M, Marciniak B, Kontek R, Chudoba D, Zdorovets MV. Boron and Gadolinium Loaded Fe 3O 4 Nanocarriers for Potential Application in Neutron Capture Therapy. Int J Mol Sci 2021; 22:8687. [PMID: 34445393 PMCID: PMC8395504 DOI: 10.3390/ijms22168687] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/15/2021] [Revised: 08/09/2021] [Accepted: 08/09/2021] [Indexed: 11/16/2022] Open
Abstract
In this article, a novel method of simultaneous carborane- and gadolinium-containing compounds as efficient agents for neutron capture therapy (NCT) delivery via magnetic nanocarriers is presented. The presence of both Gd and B increases the efficiency of NCT and using nanocarriers enhances selectivity. These factors make NCT not only efficient, but also safe. Superparamagnetic Fe3O4 nanoparticles were treated with silane and then the polyelectrolytic layer was formed for further immobilization of NCT agents. Fourier-transform infrared spectroscopy (FTIR), X-ray diffraction (XRD), energy dispersive X-ray (EDX), ultraviolet-visible (UV-Vis) and Mössbauer spectroscopies, dynamic light scattering (DLS), scanning electron microscopy (SEM), vibrating-sample magnetometry (VSM) were applied for the characterization of the chemical and element composition, structure, morphology and magnetic properties of nanocarriers. The cytotoxicity effect was evaluated on different cell lines: BxPC-3, PC-3 MCF-7, HepG2 and L929, human skin fibroblasts as normal cells. average size of nanoparticles is 110 nm; magnetization at 1T and coercivity is 43.1 emu/g and 8.1, respectively; the amount of B is 0.077 mg/g and the amount of Gd is 0.632 mg/g. Successful immobilization of NCT agents, their low cytotoxicity against normal cells and selective cytotoxicity against cancer cells as well as the superparamagnetic properties of nanocarriers were confirmed by analyses above.
Collapse
Affiliation(s)
- Ilya V. Korolkov
- The Institute of Nuclear Physics, Ibragimov Str. 1, Almaty 050032, Kazakhstan; (A.V.Z.); (L.I.L.); (A.L.K.); (D.I.S.); (M.V.Z.)
- Engineering Profile Laboratory, L.N. Gumilyov Eurasian National University, Satpaev Str. 5, Nur-Sultan 010008, Kazakhstan
| | - Alexandr V. Zibert
- The Institute of Nuclear Physics, Ibragimov Str. 1, Almaty 050032, Kazakhstan; (A.V.Z.); (L.I.L.); (A.L.K.); (D.I.S.); (M.V.Z.)
- Engineering Profile Laboratory, L.N. Gumilyov Eurasian National University, Satpaev Str. 5, Nur-Sultan 010008, Kazakhstan
| | - Lana I. Lissovskaya
- The Institute of Nuclear Physics, Ibragimov Str. 1, Almaty 050032, Kazakhstan; (A.V.Z.); (L.I.L.); (A.L.K.); (D.I.S.); (M.V.Z.)
- Engineering Profile Laboratory, L.N. Gumilyov Eurasian National University, Satpaev Str. 5, Nur-Sultan 010008, Kazakhstan
| | - K. Ludzik
- Department of Physical Chemistry, University of Lodz, 90-236 Lodz, Poland
- Frank Laboratory of Neutron Physics, Joint Institute for Nuclear Research, Dubna 141980, Russia; (M.J.); (D.C.)
| | - M. Anisovich
- Republican Unitary Enterprise, Scientific-Practical Centre of Hygiene, 220012 Minsk, Belarus; (M.A.); (M.V.)
| | - Artem L. Kozlovskiy
- The Institute of Nuclear Physics, Ibragimov Str. 1, Almaty 050032, Kazakhstan; (A.V.Z.); (L.I.L.); (A.L.K.); (D.I.S.); (M.V.Z.)
- Engineering Profile Laboratory, L.N. Gumilyov Eurasian National University, Satpaev Str. 5, Nur-Sultan 010008, Kazakhstan
| | - A. E. Shumskaya
- The Institute of Chemistry of New Materials, National Academy of Sciences of Belarus, 220072 Minsk, Belarus;
| | - M. Vasilyeva
- Republican Unitary Enterprise, Scientific-Practical Centre of Hygiene, 220012 Minsk, Belarus; (M.A.); (M.V.)
| | - Dmitriy I. Shlimas
- The Institute of Nuclear Physics, Ibragimov Str. 1, Almaty 050032, Kazakhstan; (A.V.Z.); (L.I.L.); (A.L.K.); (D.I.S.); (M.V.Z.)
- Engineering Profile Laboratory, L.N. Gumilyov Eurasian National University, Satpaev Str. 5, Nur-Sultan 010008, Kazakhstan
| | - Monika Jażdżewska
- Frank Laboratory of Neutron Physics, Joint Institute for Nuclear Research, Dubna 141980, Russia; (M.J.); (D.C.)
- Faculty of Physics, Adam Mickiewicz University, 61-614 Poznan, Poland
| | - Beata Marciniak
- Laboratory of Cytogenetics, Faculty of Biology and Enviromental Protection, University of Lodz, 90-231 Lodz, Poland; (B.M.); (R.K.)
| | - Renata Kontek
- Laboratory of Cytogenetics, Faculty of Biology and Enviromental Protection, University of Lodz, 90-231 Lodz, Poland; (B.M.); (R.K.)
| | - Dorota Chudoba
- Frank Laboratory of Neutron Physics, Joint Institute for Nuclear Research, Dubna 141980, Russia; (M.J.); (D.C.)
- Faculty of Physics, Adam Mickiewicz University, 61-614 Poznan, Poland
| | - Maxim V. Zdorovets
- The Institute of Nuclear Physics, Ibragimov Str. 1, Almaty 050032, Kazakhstan; (A.V.Z.); (L.I.L.); (A.L.K.); (D.I.S.); (M.V.Z.)
- Engineering Profile Laboratory, L.N. Gumilyov Eurasian National University, Satpaev Str. 5, Nur-Sultan 010008, Kazakhstan
- Department of Intelligent Information Technologies, Ural Federal University, Mira Str. 19, Ekaterinburg 620002, Russia
| |
Collapse
|
12
|
Yang H, Zhang D, Liang R, Liu Z, Song Y, Yang L, Liu A. Formation of Multiple‐Helical Core‐Shell Structure from Polyphenyl and Boron Nitride Nanotube. ADVANCED THEORY AND SIMULATIONS 2021. [DOI: 10.1002/adts.202100078] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
Affiliation(s)
- Houbo Yang
- College of Mechanical and Vehicle Engineering Linyi University Linyi Shandong 276005 China
| | - Danhui Zhang
- College of Mechanical and Vehicle Engineering Linyi University Linyi Shandong 276005 China
| | - Ruquan Liang
- College of Mechanical and Vehicle Engineering Linyi University Linyi Shandong 276005 China
| | - Zhongkui Liu
- College of Mechanical and Vehicle Engineering Linyi University Linyi Shandong 276005 China
| | - Yuanmei Song
- College of Mechanical and Vehicle Engineering Linyi University Linyi Shandong 276005 China
| | - Liu Yang
- College of Mechanical and Vehicle Engineering Linyi University Linyi Shandong 276005 China
| | - Anmin Liu
- State Key Laboratory of Fine Chemicals School of Chemical Engineering Dalian University of Technology Panjin 124221 China
| |
Collapse
|
13
|
Ciobanasu C. Peptides-based therapy and diagnosis. Strategies for non-invasive therapies in cancer. J Drug Target 2021; 29:1063-1079. [PMID: 33775187 DOI: 10.1080/1061186x.2021.1906885] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]
Abstract
In recent years, remarkable progress was registered in the field of cancer research. Though, cancer still represents a major cause of death and cancer metastasis a problem seeking for urgent solutions as it is the main reason for therapeutic failure. Unfortunately, the most common chemotherapeutic agents are non-selective and can damage healthy tissues and cause side effects that affect dramatically the quality of life of the patients. Targeted therapy with molecules that act specifically at the tumour sites interacting with overexpressed cancer receptors is a very promising strategy for achieving the specific delivery of anticancer drugs, radioisotopes or imaging agents. This review aims to give an overview on different strategies for targeting cancer cell receptors localised either at the extracellular matrix or at the cell membrane. Molecules like antibodies, aptamers and peptides targeting the cell surface are presented with advantages and disadvantages, with emphasis on peptides. The most representative peptides are described, including cell penetrating peptides, homing and anticancer peptides with particular consideration on recent discoveries.
Collapse
Affiliation(s)
- Corina Ciobanasu
- Sciences Department, Institute for Interdisciplinary Research, Alexandru I. Cuza University, Iaşi, Romania
| |
Collapse
|
14
|
Zhang D, Liang R, Yang H, Song Y, Shi J, Zhang D, Yang L, Liu A. Formation of multiple helical structures induced by boron nitride nanotubes. Chem Phys 2021. [DOI: 10.1016/j.chemphys.2021.111135] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/01/2023]
|
15
|
Pellico J, Gawne PJ, T M de Rosales R. Radiolabelling of nanomaterials for medical imaging and therapy. Chem Soc Rev 2021; 50:3355-3423. [PMID: 33491714 DOI: 10.1039/d0cs00384k] [Citation(s) in RCA: 112] [Impact Index Per Article: 37.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/20/2022]
Abstract
Nanomaterials offer unique physical, chemical and biological properties of interest for medical imaging and therapy. Over the last two decades, there has been an increasing effort to translate nanomaterial-based medicinal products (so-called nanomedicines) into clinical practice and, although multiple nanoparticle-based formulations are clinically available, there is still a disparity between the number of pre-clinical products and those that reach clinical approval. To facilitate the efficient clinical translation of nanomedicinal-drugs, it is important to study their whole-body biodistribution and pharmacokinetics from the early stages of their development. Integrating this knowledge with that of their therapeutic profile and/or toxicity should provide a powerful combination to efficiently inform nanomedicine trials and allow early selection of the most promising candidates. In this context, radiolabelling nanomaterials allows whole-body and non-invasive in vivo tracking by the sensitive clinical imaging techniques positron emission tomography (PET), and single photon emission computed tomography (SPECT). Furthermore, certain radionuclides with specific nuclear emissions can elicit therapeutic effects by themselves, leading to radionuclide-based therapy. To ensure robust information during the development of nanomaterials for PET/SPECT imaging and/or radionuclide therapy, selection of the most appropriate radiolabelling method and knowledge of its limitations are critical. Different radiolabelling strategies are available depending on the type of material, the radionuclide and/or the final application. In this review we describe the different radiolabelling strategies currently available, with a critical vision over their advantages and disadvantages. The final aim is to review the most relevant and up-to-date knowledge available in this field, and support the efficient clinical translation of future nanomedicinal products for in vivo imaging and/or therapy.
Collapse
Affiliation(s)
- Juan Pellico
- School of Biomedical Engineering & Imaging Sciences, King's College London, St. Thomas' Hospital, London SE1 7EH, UK.
| | | | | |
Collapse
|